Article Contents ::
- 1 Details About Generic Salt :: Dopamine
- 2 Main Medicine Class:: Vasopressor
- 3 (DOE-puh-meen HIGH-droe-KLOR-ide) Intropin, Revimine Class: Vasopressor
- 4 Drugs Class ::
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
Details About Generic Salt :: Dopamine
Main Medicine Class:: Vasopressor
(DOE-puh-meen HIGH-droe-KLOR-ide)
Intropin, Revimine
Class: Vasopressor
Drugs Class ::
Action Stimulates beta1 receptors in heart, causing more complete and forceful contractions (inotropy). Also acts on alpha receptors (dose dependent) and has dopaminergic effects.
Indications for Drugs ::
Indications Correction of hemodynamic imbalances present in shock after MI; trauma, endotoxic septicemia, surgery and renal failure or imbalances in conditions of chronic refractory cardiac decompensation (eg, CHF).
Drug Dose ::
Route/Dosage
ADULTS: IV Initial dose: 2 to 5 mcg/kg/min with incremental changes of 5 to 10 mcg/kg/min at 10 to 15 min intervals until adequate response is noted. Most patients are maintained at < 20 mcg/kg/min. If dosage exceeds 50 mcg/kg/min, assess renal function frequently.
Contraindication ::
Contraindications Pheochromocytoma; uncorrected tachyarrhythmias; ventricular fibrillation.
Drug Precautions ::
Precautions
Pregnancy: Category C. Lactation: Undetermined. Children: Safety and efficacy not established. Special risk patients: Do not give in presence of uncorrected tachyarrhythmias or ventricular fibrillation. Extravasation: Avoid by infusing into large vein and monitoring infusion carefully. Sulfite sensitivity: Use caution in sulfite-sensitive individuals; some commercial preparations contain sodium bisulfite.
PATIENT CARE CONSIDERATIONS |
|
Drug Side Effects ::
Adverse Reactions
CV: Ectopic beats; tachycardia; anginal pain; palpitation; hypotension; vasoconstriction; ventricular arrhythmias (at high doses); hypertension. CNS: Headache; anxiety. EENT: Dilated pupils (at high doses). GI: Nausea; vomiting. GU: Decreased urine output. RESP Dyspnea. OTHER: Gangrene of extremities.
Drug Mode of Action ::
Action Stimulates beta1 receptors in heart, causing more complete and forceful contractions (inotropy). Also acts on alpha receptors (dose dependent) and has dopaminergic effects.
Drug Interactions ::
Interactions
Furazolidone, methyldopa, rauwolfia alkaloids: Hypertension may result. Guanethidine: Antihypertensive effects of guanethidine may be negated. Monoamine oxidase inhibitors: May greatly increase pressor response from dopamine. Phenytoin: Severe hypotension and bradycardia may result after concomitant administration with dopamine. Tricyclic antidepressants: May decrease pressor response from dopamine. Incompatibilities: Chemically incompatible with alkaline solutions (drug is inactivated).
Drug Assesment ::
Assessment/Interventions
- Obtain patient history, including drug history and any known allergies.
- Monitor vital signs and ECG closely throughout therapy.
- Monitor I&O regularly. Notify physician promptly if urine output decreases.
- Monitor IV rate for free flow throughout administration.
- Monitor central venous pressure or pulmonary wedge pressure if possible during infusion.
- Observe infusion site for extravasation. If extravasation occurs, treat by infiltrating the area with 10 to 15 ml of normal saline containing 5 to 10 mg of phentolamine.
- Notify physician immediately if these signs occur: significant changes in vital signs, ECG changes (arrhythmias, tachycardia); deterioration of peripheral pulses and cold, mottled extremities.
|
Drug Storage/Management ::
Administration/Storage
- Administer by IV infusion only. Metering device is essential for controlling rate of flow.
- Dopamine is potent drug. Dilute before use if not prediluted.
- Dilute medication just prior to administration. Solution is stable for 24 hr after dilution.
- Do not use if solution is discolored.
- Store at room temperature and protect from light. Discard dissolved solution.
Drug Notes ::
Patient/Family Education
- Instruct patient to inform nurse immediately if these signs occur: chest pain, dyspnea, numbness, tingling or burning of extremities and discomfort at IV site.